News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
745,953 Results
Type
Article (47715)
Company Profile (461)
Press Release (697777)
Multimedia
Podcasts (85)
Webinars (13)
Section
Business (217145)
Career Advice (2365)
Deals (37009)
Drug Delivery (107)
Drug Development (85104)
Employer Resources (182)
FDA (16909)
Job Trends (15691)
News (365108)
Policy (34200)
Tag
Academia (2840)
Accelerated approval (6)
Adcomms (25)
Allergies (89)
Alliances (53225)
ALS (94)
Alzheimer's disease (1469)
Antibody-drug conjugate (ADC) (141)
Approvals (16891)
Artificial intelligence (286)
Autoimmune disease (25)
Automation (16)
Bankruptcy (376)
Best Places to Work (12282)
BIOSECURE Act (21)
Biosimilars (112)
Biotechnology (339)
Bladder cancer (84)
Brain cancer (28)
Breast cancer (293)
Cancer (2368)
Cardiovascular disease (193)
Career advice (1977)
Career pathing (33)
CAR-T (160)
Cell therapy (457)
Cervical cancer (19)
Clinical research (68927)
Collaboration (902)
Company closure (1)
Compensation (544)
Complete response letters (27)
COVID-19 (2717)
CRISPR (46)
C-suite (264)
Cystic fibrosis (106)
Data (2259)
Decentralized trials (2)
Denatured (30)
Depression (53)
Diabetes (283)
Diagnostics (6760)
Digital health (19)
Diversity (8)
Diversity, equity & inclusion (45)
Drug discovery (130)
Drug pricing (113)
Drug shortages (27)
Duchenne muscular dystrophy (100)
Earnings (90067)
Editorial (44)
Employer branding (22)
Employer resources (157)
Events (121226)
Executive appointments (769)
FDA (18220)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (799)
Gene editing (115)
Generative AI (24)
Gene therapy (337)
GLP-1 (790)
Government (4657)
Grass and pollen (4)
Guidances (67)
Healthcare (20165)
Huntington's disease (24)
IgA nephropathy (31)
Immunology and inflammation (132)
Indications (30)
Infectious disease (2868)
Inflammatory bowel disease (149)
Inflation Reduction Act (11)
Influenza (55)
Intellectual property (100)
Interviews (384)
IPO (17094)
IRA (45)
Job creations (3863)
Job search strategy (1681)
Kidney cancer (10)
Labor market (38)
Layoffs (516)
Leadership (24)
Legal (8258)
Liver cancer (78)
Lung cancer (332)
Lymphoma (156)
Machine learning (7)
Management (63)
Manufacturing (326)
MASH (71)
Medical device (14095)
Medtech (14100)
Mergers & acquisitions (20467)
Metabolic disorders (745)
Multiple sclerosis (83)
NASH (20)
Neurodegenerative disease (105)
Neuropsychiatric disorders (33)
Neuroscience (2051)
NextGen: Class of 2025 (7177)
Non-profit (4859)
Now hiring (39)
Obesity (401)
Opinion (245)
Ovarian cancer (77)
Pain (93)
Pancreatic cancer (85)
Parkinson's disease (157)
Partnered (21)
Patents (239)
Patient recruitment (116)
Peanut (49)
People (61840)
Pharmaceutical (91)
Pharmacy benefit managers (19)
Phase I (21642)
Phase II (30381)
Phase III (22500)
Pipeline (1237)
Policy (158)
Postmarket research (2670)
Preclinical (9341)
Press Release (72)
Prostate cancer (111)
Psychedelics (37)
Radiopharmaceuticals (266)
Rare diseases (414)
Real estate (6369)
Recruiting (69)
Regulatory (23498)
Reports (46)
Research institute (2568)
Resumes & cover letters (390)
Rett syndrome (5)
RNA editing (5)
RSV (43)
Schizophrenia (78)
Series A (142)
Series B (90)
Service/supplier (14)
Sickle cell disease (57)
Special edition (17)
Spinal muscular atrophy (162)
Sponsored (33)
Startups (3874)
State (2)
Stomach cancer (16)
Supply chain (70)
Tariffs (44)
The Weekly (53)
Vaccines (746)
Venture capitalists (43)
Weight loss (273)
Women's health (37)
Worklife (18)
Date
Last 7 days (928)
Last 30 days (2603)
Last 365 days (34289)
2025 (11319)
2024 (37018)
2023 (41875)
2022 (53244)
2021 (57875)
2020 (56479)
2019 (49662)
2018 (37554)
2017 (34348)
2016 (33959)
2015 (40175)
2014 (33837)
2013 (28950)
2012 (31128)
2011 (31649)
2010 (29690)
Location
Africa (814)
Alabama (59)
Alaska (7)
Arizona (252)
Arkansas (14)
Asia (41664)
Australia (7016)
California (6349)
Canada (2052)
China (545)
Colorado (275)
Connecticut (296)
Delaware (152)
Europe (92814)
Florida (927)
Georgia (219)
Idaho (62)
Illinois (585)
India (26)
Indiana (318)
Iowa (12)
Japan (168)
Kansas (108)
Kentucky (28)
Louisiana (11)
Maine (62)
Maryland (927)
Massachusetts (4840)
Michigan (244)
Minnesota (408)
Mississippi (2)
Missouri (90)
Montana (31)
Nebraska (25)
Nevada (65)
New Hampshire (68)
New Jersey (1792)
New Mexico (31)
New York (1804)
North Carolina (1071)
North Dakota (9)
Northern California (2740)
Ohio (215)
Oklahoma (15)
Oregon (40)
Pennsylvania (1408)
Puerto Rico (13)
Rhode Island (34)
South America (1229)
South Carolina (24)
South Dakota (1)
Southern California (2369)
Tennessee (104)
Texas (945)
United States (24210)
Utah (188)
Virginia (158)
Washington D.C. (67)
Washington State (586)
West Virginia (3)
Wisconsin (66)
745,953 Results for "lead therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Nutcracker Therapeutics to Showcase NMU-Symphony™ Platform for Personalized Cancer Therapeutics at Leading Industry Conferences
May 1, 2025
·
3 min read
Press Releases
Epsilogen Announces Acquisition of TigaTx, Inc. to Create World’s Leading Pan-Isotype Cancer Antibody Company
April 7, 2025
·
6 min read
Press Releases
Autonomix Medical, Inc. Engages Leading Medical Experts to Guide U.S. Clinical and Regulatory Path in Pancreatic Cancer Pain
April 9, 2025
·
3 min read
Press Releases
Autonomix Medical, Inc. Technology and Early Proof-of-Concept Study Results to be Featured in Poster Presentation at the World-Leading Course in Interventional Cardiovascular Medicine, EuroPCR
April 24, 2025
·
2 min read
Biotech Bay
CERo Therapeutics, Inc. Completes IND-Enabling Activities Following Successful Manufacturing Runs for Lead Compound CER-1236
CERo Therapeutics Holdings, Inc., an innovative immunotherapy company seeking to advance the next generation of engineered T cell therapeutics that employ phagocytic mechanisms, announced it successfully executed pre-IND manufacturing activities for its lead therapeutic, CER-1236.
June 13, 2024
·
4 min read
Press Releases
Prime Therapeutics highlights industry-leading GLP-1 research at AMCP 2025
April 1, 2025
·
4 min read
Press Releases
Pretzel Therapeutics Initiates Phase 1 Clinical Study Evaluating PX578, Lead Therapeutic in its Bioenergetics Restoration Franchise
April 3, 2025
·
3 min read
Press Releases
Plus Therapeutics Introduces REYOBIQ™, FDA-Accepted Proprietary Name for Lead Drug Candidate
March 20, 2025
·
2 min read
Press Releases
Avacta Therapeutics Presents Data from Lead pre|CISION® Candidate FAP-Dox (AVA6000) at the 2025 AACR Annual Meeting
April 29, 2025
·
5 min read
Press Releases
Aspire Biopharma Holdings, Inc., Provides an Update on Lead Product Candidate: High-Dose, Sublingual Aspirin
February 26, 2025
·
6 min read
1 of 74,596
Next
